Summary
This study developed and validated metabolomics-based biomarkers for major classes of dietary fatty acid intake in a large cohort of postmenopausal United States women (n=81,894), using serum and urine metabolite profiles calibrated against controlled feeding data. Higher saturated and polyunsaturated fatty acid densities showed weak or null associations with cardiovascular disease risk after controlling for other dietary factors, though positive associations were observed for some cancer types and type 2 diabetes. The findings suggest that observational associations between specific fatty acid classes and chronic disease in this population may be modest and sensitive to adjustment for related dietary factors.
Regional applicability
This study was conducted in the United States and enrolled postmenopausal women aged 50-79, so direct application to United Kingdom practice requires caution regarding age group applicability and dietary patterns. However, the metabolomics methodology and biomarker validation approach are transferable, and the null or weak associations with CVD risk align with recent United Kingdom and European dietary guidance questioning the strength of saturated fat restrictions for cardiovascular benefit.
Key measures
Serum and urine metabolite profiles; biomarker-calibrated fatty acid densities (SFA, MUFA, PUFA); hazard ratios for CVD, cancer, and T2D incidence
Outcomes reported
Development and validation of serum and urine metabolomics biomarkers for saturated, monounsaturated, and polyunsaturated fatty acid densities, and assessment of their associations with cardiovascular disease, cancer, and type 2 diabetes incidence over approximately 20 years of follow-up.
Topic tags
Dig deeper with Pulse AI.
Ask about this record, its theme or its relevance to UK farming and policy. Pulse AI uses selected catalogue evidence and cites the sources it draws on.